Interestingly, our observations are in line with recent findings suggesting that a subpopulation of TAMs, defined as CD206+/TIE2Hi/CXCR4Hi, accumulate around blood vessels after chemotherapy in breast cancer, where they promote tumor revascularization and relapse, partly by release of VEGF (Hughes et al, 2015). Here, MRC1 is linked to breast cancer.